The estimated Net Worth of Mary Z.Zhang Jack Y. Luo is at least 72.7 百万$ dollars as of 10 January 2024. Mary Luo owns over 131,386 units of Amphastar Pharmaceuticals Inc stock worth over 49,776,029$ and over the last few years he sold AMPH stock worth over 19,971,316$. In addition, he makes 2,976,100$ as Chief Operating Officer、 Chief Scientist and Chairman of the Board at Amphastar Pharmaceuticals Inc.
Mary has made over 2 trades of the Amphastar Pharmaceuticals Inc stock since 2024, according to the Form 4 filled with the SEC. Most recently he sold 131,386 units of AMPH stock worth 7,172,362$ on 10 January 2024.
The largest trade he's ever made was selling 219,800 units of Amphastar Pharmaceuticals Inc stock on 8 January 2024 worth over 12,798,954$. On average, Mary trades about 175,593 units every 1 days since 2024. As of 10 January 2024 he still owns at least 1,104,416 units of Amphastar Pharmaceuticals Inc stock.
You can see the complete history of Mary Luo stock trades at the bottom of the page.
Dr. Mary Ziping Luo Ph.D. serves as Chief Operating Officer, Chief Scientist and Chairman of the Board of the Company. Dr. Luo co-founded our company in 1996 and has served as our Chief Operating Officer and chairman of our board of directors since our inception and as Secretary from 1997 to April 2004. Dr. Luo has also served as our Chief Scientist since 2005. Dr. Luo co-founded Applied Physics & Chemistry Laboratories, Inc., or APCL, a full service chemical analytical laboratory, in May 1989, where she held the position of Chief Operating Officer. Dr. Luo is a professor emeritus of chemistry at California State Polytechnic University, Pomona and is named as the inventor on several U.S. and foreign patents. Dr. Luo received a Ph.D. in chemistry from Princeton University and was a Post Doctoral Research Associate at the California Institute of Technology.
As the Chief Operating Officer、 Chief Scientist and Chairman of the Board of Amphastar Pharmaceuticals Inc, the total compensation of Mary Luo at Amphastar Pharmaceuticals Inc is 2,976,100$. There are 1 executives at Amphastar Pharmaceuticals Inc getting paid more, with Jack Zhang having the highest compensation of 5,969,740$.
Mary Luo is 70, he's been the Chief Operating Officer、 Chief Scientist and Chairman of the Board of Amphastar Pharmaceuticals Inc since 2005. There are 6 older and 10 younger executives at Amphastar Pharmaceuticals Inc. The oldest executive at Amphastar Pharmaceuticals Inc is Richard Koo, 79, who is the Independent Director.
Over the last 10 years, insiders at Amphastar Pharmaceuticals Inc have traded over 72,457,295$ worth of Amphastar Pharmaceuticals Inc stock and bought 66,100 units worth 921,987$ . The most active insiders traders include Jack Y.Luo Mary Z. Zhang、Richard K Prins、William J Peters. On average, Amphastar Pharmaceuticals Inc executives and independent directors trade stock every 11 days with the average trade being worth of 1,459,051$. The most recent stock trade was executed by Floyd F. Petersen on 5 September 2024, trading 3,000 units of AMPH stock currently worth 139,410$.
amphastar pharmaceuticals, inc., headquartered in rancho cucamonga, california, established in 1996, is a recognized specialty pharmaceutical company that uses state-of-the-art, cgmp compliant facilities to develop, manufacture, and market injectable and inhalation products. in addition to the corporate headquarters, amphastar has five manufacturing facilities located in the united states, china and europe along with a state-of-the-art new drug research center. amphastar and its subsidiaries each have their own distinct focus that they skillfully bring together to meet the varied needs of the pharmaceutical industry. we currently produce approximately 15 injectable products while we continue to develop a portfolio of generic and branded products that target large markets with high technical barriers to entry. amphastar’s long-standing relationship with the major group purchasing organizations and drug wholesalers in the u.s. enables it to establish significant market share upon the int
Amphastar Pharmaceuticals Inc executives and other stock owners filed with the SEC include: